4cpy - Revision history

OCA at 12:14, 20 December 2023

2023-12-20T12:14:33Z

← Older revision		Revision as of 12:14, 20 December 2023
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4cpy]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Influenza_B_virus Influenza B virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CPY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4CPY FirstGlance]. <br>		<table><tr><td colspan='2'>[[4cpy]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Influenza_B_virus Influenza B virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CPY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4CPY FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=G39:(3R,4R,5S)-4-(ACETYLAMINO)-5-AMINO-3-(PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC+ACID'>G39</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>		</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.8Å</td></tr>
			<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=G39:(3R,4R,5S)-4-(ACETYLAMINO)-5-AMINO-3-(PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC+ACID'>G39</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4cpy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cpy OCA], [https://pdbe.org/4cpy PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4cpy RCSB], [https://www.ebi.ac.uk/pdbsum/4cpy PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4cpy ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4cpy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cpy OCA], [https://pdbe.org/4cpy PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4cpy RCSB], [https://www.ebi.ac.uk/pdbsum/4cpy PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4cpy ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
	[[https://www.uniprot.org/uniprot/U5XBU0_9INFB U5XBU0_9INFB]] Catalyzes the removal of terminal sialic acid residues from viral and cellular glycoconjugates.[RuleBase:RU361252]		[https://www.uniprot.org/uniprot/U5XBU0_9INFB U5XBU0_9INFB] Catalyzes the removal of terminal sialic acid residues from viral and cellular glycoconjugates.[RuleBase:RU361252]
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 18:		Line 19:
	</div>		</div>
	<div class="pdbe-citations 4cpy" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 4cpy" style="background-color:#fffaf0;"></div>

			==See Also==
			*[[Neuraminidase 3D structures\|Neuraminidase 3D structures]]
	== References ==		== References ==
	<references/>		<references/>

OCA at 07:26, 14 September 2022

2022-09-14T07:26:59Z

← Older revision		Revision as of 07:26, 14 September 2022
Line 3:		Line 3:
	<StructureSection load='4cpy' size='340' side='right'caption='[[4cpy]], [[Resolution\|resolution]] 1.80Å' scene=''>		<StructureSection load='4cpy' size='340' side='right'caption='[[4cpy]], [[Resolution\|resolution]] 1.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4cpy]] is a 2 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Influenza_b_virus~~ Influenza b virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CPY OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4CPY FirstGlance]. <br>		<table><tr><td colspan='2'>[[4cpy]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Influenza_B_virus Influenza B virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CPY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4CPY FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=G39:(3R,4R,5S)-4-(ACETYLAMINO)-5-AMINO-3-(PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC+ACID'>G39</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene~~></td></tr>~~		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=G39:(3R,4R,5S)-4-(ACETYLAMINO)-5-AMINO-3-(PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC+ACID'>G39</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
	~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4cpl\|4cpl]], [[4cpm\|4cpm]], [[4cpn\|4cpn]], [[4cpo\|4cpo]], [[4cpz\|4cpz]]</td></tr>~~		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4cpy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cpy OCA], [https://pdbe.org/4cpy PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4cpy RCSB], [https://www.ebi.ac.uk/pdbsum/4cpy PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4cpy ProSAT]</span></td></tr>
	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Exo-alpha-sialidase Exo-alpha-sialidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.18 3.2.1.18] </span></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4cpy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cpy OCA], [~~http~~://pdbe.org/4cpy PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4cpy RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4cpy PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4cpy ProSAT]</span></td></tr>
	</table>		</table>
			== Function ==
			[[https://www.uniprot.org/uniprot/U5XBU0_9INFB U5XBU0_9INFB]] Catalyzes the removal of terminal sialic acid residues from viral and cellular glycoconjugates.[RuleBase:RU361252]
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 22:		Line 22:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
	~~[[Category: Exo-alpha-sialidase]]~~		[[Category: Influenza B virus]]
	[[Category: Influenza b virus]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
	[[Category: Caro, V]]		[[Category: Caro V]]
	[[Category: Casalegno~~, J S~~]]		[[Category: Casalegno JS]]
	[[Category: Cattle, N]]		[[Category: Cattle N]]
	[[Category: Collins~~, P J~~]]		[[Category: Collins PJ]]
	[[Category: Daniels~~, R S~~]]		[[Category: Daniels RS]]
	[[Category: Escuret, V]]		[[Category: Escuret V]]
	[[Category: Ferraris, O]]		[[Category: Ferraris O]]
	[[Category: Frobert, E]]		[[Category: Frobert E]]
	[[Category: Gamblin~~, S J~~]]		[[Category: Gamblin SJ]]
	[[Category: Lina, B]]		[[Category: Lina B]]
	[[Category: McCauley~~, J W~~]]		[[Category: McCauley JW]]
	[[Category: Ottmann, M]]		[[Category: Ottmann M]]
	[[Category: Sabatier, M]]		[[Category: Sabatier M]]
	[[Category: Skehel~~, J J~~]]		[[Category: Skehel JJ]]
	[[Category: Vachieri~~, S G~~]]		[[Category: Vachieri SG]]
	[[Category: Valette, M]]		[[Category: Valette M]]
	[[Category: Valla, F]]		[[Category: Valla F]]
	~~[[Category: Hydrolase]]~~
	~~[[Category: Tamiflu~~]]

OCA at 09:52, 20 March 2019

2019-03-20T09:52:31Z

← Older revision		Revision as of 09:52, 20 March 2019
Line 1:		Line 1:

	==Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Oseltamivir==		==Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Oseltamivir==
	<StructureSection load='4cpy' size='340' side='right' caption='[[4cpy]], [[Resolution\|resolution]] 1.80Å' scene=''>		<StructureSection load='4cpy' size='340' side='right'caption='[[4cpy]], [[Resolution\|resolution]] 1.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4cpy]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Influenza_b_virus Influenza b virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CPY OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CPY FirstGlance]. <br>		<table><tr><td colspan='2'>[[4cpy]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Influenza_b_virus Influenza b virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CPY OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CPY FirstGlance]. <br>
Line 24:		Line 24:
	[[Category: Exo-alpha-sialidase]]		[[Category: Exo-alpha-sialidase]]
	[[Category: Influenza b virus]]		[[Category: Influenza b virus]]
			[[Category: Large Structures]]
	[[Category: Caro, V]]		[[Category: Caro, V]]
	[[Category: Casalegno, J S]]		[[Category: Casalegno, J S]]

OCA at 17:05, 2 January 2017

2017-01-02T17:05:39Z

← Older revision		Revision as of 17:05, 2 January 2017
Line 1:		Line 1:

	==Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Oseltamivir==		==Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Oseltamivir==
	<StructureSection load='4cpy' size='340' side='right' caption='[[4cpy]], [[Resolution\|resolution]] 1.80Å' scene=''>		<StructureSection load='4cpy' size='340' side='right' caption='[[4cpy]], [[Resolution\|resolution]] 1.80Å' scene=''>
Line 6:		Line 7:
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4cpl\|4cpl]], [[4cpm\|4cpm]], [[4cpn\|4cpn]], [[4cpo\|4cpo]], [[4cpz\|4cpz]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4cpl\|4cpl]], [[4cpm\|4cpm]], [[4cpn\|4cpn]], [[4cpo\|4cpo]], [[4cpz\|4cpz]]</td></tr>
	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Exo-alpha-sialidase Exo-alpha-sialidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.18 3.2.1.18] </span></td></tr>		<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Exo-alpha-sialidase Exo-alpha-sialidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.18 3.2.1.18] </span></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4cpy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cpy OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4cpy RCSB], [http://www.ebi.ac.uk/pdbsum/4cpy PDBsum]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4cpy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cpy OCA], [http://pdbe.org/4cpy PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4cpy RCSB], [http://www.ebi.ac.uk/pdbsum/4cpy PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4cpy ProSAT]</span></td></tr>
	</table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 16:		Line 17:
	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
			<div class="pdbe-citations 4cpy" style="background-color:#fffaf0;"></div>
	== References ==		== References ==
	<references/>		<references/>

OCA at 08:40, 20 January 2015

2015-01-20T08:40:47Z

← Older revision		Revision as of 08:40, 20 January 2015
Line 22:		Line 22:
	[[Category: Exo-alpha-sialidase]]		[[Category: Exo-alpha-sialidase]]
	[[Category: Influenza b virus]]		[[Category: Influenza b virus]]
	[[Category: Caro, V.]]		[[Category: Caro, V]]
	[[Category: Casalegno, J S.]]		[[Category: Casalegno, J S]]
	[[Category: Cattle, N.]]		[[Category: Cattle, N]]
	[[Category: Collins, P J.]]		[[Category: Collins, P J]]
	[[Category: Daniels, R S.]]		[[Category: Daniels, R S]]
	[[Category: Escuret, V.]]		[[Category: Escuret, V]]
	[[Category: Ferraris, O.]]		[[Category: Ferraris, O]]
	[[Category: Frobert, E.]]		[[Category: Frobert, E]]
	[[Category: Gamblin, S J.]]		[[Category: Gamblin, S J]]
	[[Category: Lina, B.]]		[[Category: Lina, B]]
	[[Category: McCauley, J W.]]		[[Category: McCauley, J W]]
	[[Category: Ottmann, M.]]		[[Category: Ottmann, M]]
	[[Category: Sabatier, M.]]		[[Category: Sabatier, M]]
	[[Category: Skehel, J J.]]		[[Category: Skehel, J J]]
	[[Category: Vachieri, S G.]]		[[Category: Vachieri, S G]]
	[[Category: Valette, M.]]		[[Category: Valette, M]]
	[[Category: Valla, F.]]		[[Category: Valla, F]]
	[[Category: Hydrolase]]		[[Category: Hydrolase]]
	[[Category: Tamiflu]]		[[Category: Tamiflu]]

OCA at 05:45, 8 October 2014

2014-10-08T05:45:23Z

← Older revision		Revision as of 05:45, 8 October 2014
Line 2:		Line 2:
	<StructureSection load='4cpy' size='340' side='right' caption='[[4cpy]], [[Resolution\|resolution]] 1.80Å' scene=''>		<StructureSection load='4cpy' size='340' side='right' caption='[[4cpy]], [[Resolution\|resolution]] 1.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4cpy]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Influenza_b_virus Influenza b virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CPY OCA]. <br>		<table><tr><td colspan='2'>[[4cpy]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Influenza_b_virus Influenza b virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CPY OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CPY FirstGlance]. <br>
	</td></tr><tr><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=G39:(3R,4R,5S)-4-(ACETYLAMINO)-5-AMINO-3-(PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC+ACID'>G39</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene><br>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=G39:(3R,4R,5S)-4-(ACETYLAMINO)-5-AMINO-3-(PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC+ACID'>G39</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
	<tr><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4cpl\|4cpl]], [[4cpm\|4cpm]], [[4cpn\|4cpn]], [[4cpo\|4cpo]], [[4cpz\|4cpz]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4cpl\|4cpl]], [[4cpm\|4cpm]], [[4cpn\|4cpn]], [[4cpo\|4cpo]], [[4cpz\|4cpz]]</td></tr>
	<tr><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/~~Glucokinase Glucokinase~~], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.2 ~~2.7~~.1.2] </span></td></tr>		<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Exo-alpha-sialidase Exo-alpha-sialidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.18 3.2.1.18] </span></td></tr>
	<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4cpy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cpy OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4cpy RCSB], [http://www.ebi.ac.uk/pdbsum/4cpy PDBsum]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4cpy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cpy OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4cpy RCSB], [http://www.ebi.ac.uk/pdbsum/4cpy PDBsum]</span></td></tr>
	<table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 14:		Line 14:
	A novel I221 L substitution in neuraminidase confers high level resistance to oseltamivir in influenza B viruses.,Escuret V, Collins PJ, Casalegno JS, Vachieri SG, Cattle N, Ferraris O, Sabatier M, Frobert E, Caro V, Skehel JJ, Gamblin S, Valla F, Valette M, Ottmann M, McCauley JW, Daniels RS, Lina B J Infect Dis. 2014 May 3. PMID:24795482<ref>PMID:24795482</ref>		A novel I221 L substitution in neuraminidase confers high level resistance to oseltamivir in influenza B viruses.,Escuret V, Collins PJ, Casalegno JS, Vachieri SG, Cattle N, Ferraris O, Sabatier M, Frobert E, Caro V, Skehel JJ, Gamblin S, Valla F, Valette M, Ottmann M, McCauley JW, Daniels RS, Lina B J Infect Dis. 2014 May 3. PMID:24795482<ref>PMID:24795482</ref>

	From ~~MEDLINEÂ®~~/~~PubMedÂ®~~, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
	== References ==		== References ==

OCA at 07:19, 14 May 2014

2014-05-14T07:19:19Z

@@ Line 1: / Line 1: @@
-'''Unreleased structure'''
+==Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Oseltamivir==
-The entry 4cpy is ON HOLD  until Paper Publication
+A novel I221 L substitution in neuraminidase confers high level resistance to oseltamivir in influenza B viruses.,Escuret V, Collins PJ, Casalegno JS, Vachieri SG, Cattle N, Ferraris O, Sabatier M, Frobert E, Caro V, Skehel JJ, Gamblin S, Valla F, Valette M, Ottmann M, McCauley JW, Daniels RS, Lina B J Infect Dis. 2014 May 3. PMID:24795482<ref>PMID:24795482</ref>
-Authors: Vachieri, S.G., Collins, P.J., Escuret, V., Casalegno, J.S., Cattle, N., Ferraris, O., Sabatier, M., Frobert, E., Caro, V., Skehel, J.J., Gamblin, S.J., Valla, F., Valette, M., Ottmann, M., McCauley, J.W., Daniels, R.S., Lina, B., ,
+From MEDLINEÂ®/PubMedÂ®, a database of the U.S. National Library of Medicine.<br>
+</div>
-Description: Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Oseltamivir
+== References ==

OCA at 11:46, 12 March 2014

2014-03-12T11:46:05Z

← Older revision		Revision as of 11:46, 12 March 2014
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

	The entry 4cpy is ON HOLD		The entry 4cpy is ON HOLD until Paper Publication

	Authors: Vachieri, S.G., Collins, P.J., Escuret, V., Casalegno, J.S., Cattle, N., Ferraris, O., Sabatier, M., Frobert, E., Caro, V., Skehel, J.J., Gamblin, S.J., Valla, F., Valette, M., Ottmann, M., McCauley, J.W., Daniels, R.S., Lina, B., ,		Authors: Vachieri, S.G., Collins, P.J., Escuret, V., Casalegno, J.S., Cattle, N., Ferraris, O., Sabatier, M., Frobert, E., Caro, V., Skehel, J.J., Gamblin, S.J., Valla, F., Valette, M., Ottmann, M., McCauley, J.W., Daniels, R.S., Lina, B., ,

	Description: Structure of the Neuraminidase from the B-Lyon-CHU-15.216-2011 virus in complex with Oseltamivir		Description: Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Oseltamivir

OCA: Protected "4cpy" [edit=sysop:move=sysop]

2014-02-19T15:48:47Z

Protected "4cpy" [edit=sysop:move=sysop]

← Older revision	Revision as of 15:48, 19 February 2014
(No difference)

OCA: New page: '''Unreleased structure''' The entry 4cpy is ON HOLD Authors: Vachieri, S.G., Collins, P.J., Escuret, V., Casalegno, J.S., Cattle, N., Ferraris, O., Sabatier, M., Frobert, E., Caro, V.,...

2014-02-19T15:48:46Z

New page: '''Unreleased structure''' The entry 4cpy is ON HOLD Authors: Vachieri, S.G., Collins, P.J., Escuret, V., Casalegno, J.S., Cattle, N., Ferraris, O., Sabatier, M., Frobert, E., Caro, V.,...

New page

'''Unreleased structure'''

The entry 4cpy is ON HOLD

Authors: Vachieri, S.G., Collins, P.J., Escuret, V., Casalegno, J.S., Cattle, N., Ferraris, O., Sabatier, M., Frobert, E., Caro, V., Skehel, J.J., Gamblin, S.J., Valla, F., Valette, M., Ottmann, M., McCauley, J.W., Daniels, R.S., Lina, B., ,

Description: Structure of the Neuraminidase from the B-Lyon-CHU-15.216-2011 virus in complex with Oseltamivir